Incyte Corporation, a Delaware-based biopharmaceutical company, focuses on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology.

- New facility to serve as European base for Incyte’s drug development operations

- Location provides efficient access to key clinical trial experts and institutions
http://investor.incyte.com/phoenix.zhtml?c=69764&p=irol-newsArticle&ID=2034738
Find an actor

BioAlps Networking Day 201829.11.2018

L'événement aura lieu au SICHH le 29 novembre 2018 au blueFACTORY à Fribourg

AMAL Therapeutics raises 33.2 million dollars

The Geneva-based startup just announced the completion of its Series B financing round, raising in total CHF 33.2...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn